Filtered By:
Source: Experimental and Therapeutic Medicine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 541 results found since Jan 2013.
Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta ‑analysis
Exp Ther Med. 2023 Jul 6;26(2):399. doi: 10.3892/etm.2023.12098. eCollection 2023 Aug.ABSTRACTThe impact of the type of vascular access on the outcomes in the elderly haemodialysis patients is still unclear. The goal of the present study was to compare survival outcomes in elderly haemodialysis patients who received either arteriovenous graft (AVG) or arteriovenous fistula (AVF). A systematic literature search was performed in EMBASE, Cochrane, MEDLINE, ScienceDirect and Google Scholar databases for papers published from January 1954 until January 2022. Risk of bias in the selected publications was assessed by Newcastle Ot...
Source: Experimental and Therapeutic Medicine - July 31, 2023 Category: General Medicine Authors: Jia Li Hua Lu Zhen Xie Qingchao Li Hongguang Shi Source Type: research
Thrombectomy vs. medical management for large vessel occlusion strokes with minimal symptoms
Exp Ther Med. 2023 Jun 23;26(2):377. doi: 10.3892/etm.2023.12076. eCollection 2023 Aug.ABSTRACTPatients with acute ischemic stroke (AIS) presenting mild symptoms with a low National Institutes of Health Stroke Scale (NIHSS) score ≤8 and also found to have an intracranial large vessel occlusion (LVO) undergo endovascular thrombolysis (ET) or medical management alone. The current study aimed to evaluate the safety and effectiveness of medical management vs. ET therapy among patients with mild AIS symptoms (NIHSS score ≤8) accompanied by LVO. The present meta-analysis included articles involving mild AIS, LVO, thrombectom...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Iason-Stefanos Anagnostopoulos Vasiliki Epameinondas Georgakopoulou Ilias Trakas Petros Papalexis Nikolaos Trakas Demetrios A Spandidos George Fotakopoulos Source Type: research
CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer
Exp Ther Med. 2023 Jun 27;26(2):382. doi: 10.3892/etm.2023.12081. eCollection 2023 Aug.ABSTRACTIn search of an effective therapeutic target for bladder urothelial carcinoma (BLCA), the present study aimed to investigate the expression of cyclin B1 (CCNB1) and its putative mechanism in BLCA. BLCA sequencing data from Gene Expression Omnibus and The Cancer Genome Atlas were used to analyze expression of CCNB1 mRNA and high CCNB1 expression had a poorer prognosis compared with those with low expression. Immunohistochemistry (IHC) samples collected from the Human Protein Atlas database were analyzed for CCNB1 protein expressio...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Xue-Xuan Wang Hua-Yu Wu Ying Yang Miao-Miao Ma Yi-Wei Zhang Hai-Zhen Huang Sheng-Hua Li Shang-Ling Pan Jun Tang Jun-Hua Peng Source Type: research
Thrombectomy vs. medical management for large vessel occlusion strokes with minimal symptoms
Exp Ther Med. 2023 Jun 23;26(2):377. doi: 10.3892/etm.2023.12076. eCollection 2023 Aug.ABSTRACTPatients with acute ischemic stroke (AIS) presenting mild symptoms with a low National Institutes of Health Stroke Scale (NIHSS) score ≤8 and also found to have an intracranial large vessel occlusion (LVO) undergo endovascular thrombolysis (ET) or medical management alone. The current study aimed to evaluate the safety and effectiveness of medical management vs. ET therapy among patients with mild AIS symptoms (NIHSS score ≤8) accompanied by LVO. The present meta-analysis included articles involving mild AIS, LVO, thrombectom...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Iason-Stefanos Anagnostopoulos Vasiliki Epameinondas Georgakopoulou Ilias Trakas Petros Papalexis Nikolaos Trakas Demetrios A Spandidos George Fotakopoulos Source Type: research
CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer
Exp Ther Med. 2023 Jun 27;26(2):382. doi: 10.3892/etm.2023.12081. eCollection 2023 Aug.ABSTRACTIn search of an effective therapeutic target for bladder urothelial carcinoma (BLCA), the present study aimed to investigate the expression of cyclin B1 (CCNB1) and its putative mechanism in BLCA. BLCA sequencing data from Gene Expression Omnibus and The Cancer Genome Atlas were used to analyze expression of CCNB1 mRNA and high CCNB1 expression had a poorer prognosis compared with those with low expression. Immunohistochemistry (IHC) samples collected from the Human Protein Atlas database were analyzed for CCNB1 protein expressio...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Xue-Xuan Wang Hua-Yu Wu Ying Yang Miao-Miao Ma Yi-Wei Zhang Hai-Zhen Huang Sheng-Hua Li Shang-Ling Pan Jun Tang Jun-Hua Peng Source Type: research
Thrombectomy vs. medical management for large vessel occlusion strokes with minimal symptoms
Exp Ther Med. 2023 Jun 23;26(2):377. doi: 10.3892/etm.2023.12076. eCollection 2023 Aug.ABSTRACTPatients with acute ischemic stroke (AIS) presenting mild symptoms with a low National Institutes of Health Stroke Scale (NIHSS) score ≤8 and also found to have an intracranial large vessel occlusion (LVO) undergo endovascular thrombolysis (ET) or medical management alone. The current study aimed to evaluate the safety and effectiveness of medical management vs. ET therapy among patients with mild AIS symptoms (NIHSS score ≤8) accompanied by LVO. The present meta-analysis included articles involving mild AIS, LVO, thrombectom...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Iason-Stefanos Anagnostopoulos Vasiliki Epameinondas Georgakopoulou Ilias Trakas Petros Papalexis Nikolaos Trakas Demetrios A Spandidos George Fotakopoulos Source Type: research
CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer
Exp Ther Med. 2023 Jun 27;26(2):382. doi: 10.3892/etm.2023.12081. eCollection 2023 Aug.ABSTRACTIn search of an effective therapeutic target for bladder urothelial carcinoma (BLCA), the present study aimed to investigate the expression of cyclin B1 (CCNB1) and its putative mechanism in BLCA. BLCA sequencing data from Gene Expression Omnibus and The Cancer Genome Atlas were used to analyze expression of CCNB1 mRNA and high CCNB1 expression had a poorer prognosis compared with those with low expression. Immunohistochemistry (IHC) samples collected from the Human Protein Atlas database were analyzed for CCNB1 protein expressio...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Xue-Xuan Wang Hua-Yu Wu Ying Yang Miao-Miao Ma Yi-Wei Zhang Hai-Zhen Huang Sheng-Hua Li Shang-Ling Pan Jun Tang Jun-Hua Peng Source Type: research
Thrombectomy vs. medical management for large vessel occlusion strokes with minimal symptoms
Exp Ther Med. 2023 Jun 23;26(2):377. doi: 10.3892/etm.2023.12076. eCollection 2023 Aug.ABSTRACTPatients with acute ischemic stroke (AIS) presenting mild symptoms with a low National Institutes of Health Stroke Scale (NIHSS) score ≤8 and also found to have an intracranial large vessel occlusion (LVO) undergo endovascular thrombolysis (ET) or medical management alone. The current study aimed to evaluate the safety and effectiveness of medical management vs. ET therapy among patients with mild AIS symptoms (NIHSS score ≤8) accompanied by LVO. The present meta-analysis included articles involving mild AIS, LVO, thrombectom...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Iason-Stefanos Anagnostopoulos Vasiliki Epameinondas Georgakopoulou Ilias Trakas Petros Papalexis Nikolaos Trakas Demetrios A Spandidos George Fotakopoulos Source Type: research
CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer
Exp Ther Med. 2023 Jun 27;26(2):382. doi: 10.3892/etm.2023.12081. eCollection 2023 Aug.ABSTRACTIn search of an effective therapeutic target for bladder urothelial carcinoma (BLCA), the present study aimed to investigate the expression of cyclin B1 (CCNB1) and its putative mechanism in BLCA. BLCA sequencing data from Gene Expression Omnibus and The Cancer Genome Atlas were used to analyze expression of CCNB1 mRNA and high CCNB1 expression had a poorer prognosis compared with those with low expression. Immunohistochemistry (IHC) samples collected from the Human Protein Atlas database were analyzed for CCNB1 protein expressio...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Xue-Xuan Wang Hua-Yu Wu Ying Yang Miao-Miao Ma Yi-Wei Zhang Hai-Zhen Huang Sheng-Hua Li Shang-Ling Pan Jun Tang Jun-Hua Peng Source Type: research
